Literature DB >> 4339240

Meclizine and placebo in treating vertigo of vestibular origin. Relative efficacy in a double-blind study.

B Cohen, J M DeJong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4339240     DOI： 10.1001/archneur.1972.00490140033006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  14 in total

Review 1.  Dizziness in primary care patients.

Authors:  E A Warner; P M Wallach; H M Adelman; K Sahlin-Hughes
Journal:  J Gen Intern Med       Date:  1992 Jul-Aug       Impact factor: 5.128

2.  Characterization of on-target adverse events caused by TRK inhibitor therapy.

Authors:  D Liu; J Flory; A Lin; M Offin; C J Falcon; Y R Murciano-Goroff; E Rosen; R Guo; E Basu; B T Li; J J Harding; G Iyer; K Jhaveri; M M Gounder; N N Shukla; S S Roberts; J Glade-Bender; L Kaplanis; A Schram; D M Hyman; A Drilon
Journal:  Ann Oncol       Date:  2020-05-15       Impact factor: 32.976

3.  Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.

Authors:  Murat F Gorgun; Ming Zhuo; Ella W Englander
Journal:  Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.590

4.  Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.

Authors:  Mathieu Petremann; Cindy Gueguen; Viviana Delgado Betancourt; Eric Wersinger; Jonas Dyhrfjeld-Johnsen
Journal:  Br J Pharmacol       Date:  2019-08-28       Impact factor: 8.739

5.  Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H4 receptor inhibitor SENS-111 using a modified caloric test in healthy subjects.

Authors:  Frédéric Venail; Pierre Attali; Eric Wersinger; Roberto Gomeni; Sonia Poli; Sebastien Schmerber
Journal:  Br J Clin Pharmacol       Date:  2018-10-01       Impact factor: 4.335

Review 6.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 7.  Antivertigo medications and drug-induced vertigo. A pharmacological review.

Authors:  O Rascol; T C Hain; C Brefel; M Benazet; M Clanet; J L Montastruc
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

8.  Role of Phosphatidylethanolamine Biosynthesis in Herpes Simplex Virus 1-Infected Cells in Progeny Virus Morphogenesis in the Cytoplasm and in Viral Pathogenicity In Vivo.

Authors:  Jun Arii; Ayano Fukui; Yuta Shimanaka; Nozomu Kono; Hiroyuki Arai; Yuhei Maruzuru; Naoto Koyanagi; Akihisa Kato; Yasuko Mori; Yasushi Kawaguchi
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

9.  The effects of meclizine on motion sickness revisited.

Authors:  Tobias Wibble; Johanna Engström; Luca Verrecchia; Tony Pansell
Journal:  Br J Clin Pharmacol       Date:  2020-03-03       Impact factor: 4.335

10.  Meclizine inhibits mitochondrial respiration through direct targeting of cytosolic phosphoethanolamine metabolism.

Authors:  Vishal M Gohil; Lin Zhu; Charli D Baker; Valentin Cracan; Abbas Yaseen; Mohit Jain; Clary B Clish; Paul S Brookes; Marica Bakovic; Vamsi K Mootha
Journal:  J Biol Chem       Date:  2013-10-19       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.